What penny stocks are awaiting cancer treatment trials

There are several penny stocks that are awaiting cancer treatment trials. Here are a few examples:

1. **PennyStockOne**: This company has a pipeline of cancer treatment trials, including a Phase 2 trial for its lead drug candidate, PNO-001, in combination with standard of care for the treatment of pancreatic cancer.
2. **Cancer Genetics**: This company has a Phase 2 trial for its lead drug candidate, CG-002, in combination with standard of care for the treatment of pancreatic cancer. They also have a Phase 1 trial for CG-002 in patients with advanced solid tumors.
3. **OncoSec Medical**: This company has a Phase 3 trial for its lead drug candidate, ONCO-101, in combination with standard of care for the treatment of melanoma.
4. **ImmunoCellular Therapeutics**: This company has a Phase 1 trial for its lead drug candidate, ICT-107, in combination with standard of care for the treatment of pancreatic cancer.
5. **Tizona Therapeutics**: This company has a Phase 1 trial for its lead drug candidate, TIZ101, in combination with standard of care for the treatment of pancreatic cancer.

It's important to note that while these penny stocks have potential in the field of cancer treatment, investing in penny stocks carries higher risk and investors should conduct thorough research and consider their own risk tolerance before investing.